SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-22-001863
Filing Date
2022-05-11
Accepted
2022-05-11 07:14:26
Documents
5
Period of Report
2022-05-11

Document Format Files

Seq Description Document Type Size
1 6-K zk2227778.htm 6-K 14257
2 PRESS RELEASE. exhibit_1.htm EX-99 359440
3 CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, 2022 AND FOR exhibit_2.htm EX-99 370675
4 OPERATING AND FINANCIAL REVIEW AS OF MARCH 31, 2022 AND FOR THE THREE MONTHS THE exhibit_3.htm EX-99 165286
5 image00001.jpg GRAPHIC 5551
  Complete submission text file 0001178913-22-001863.txt   918555
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 22912057
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences